Late-Life Mood Disorders May Indicate Predisposition to Dementia
By Elana Gotkine HealthDay Reporter

MONDAY, June 30, 2025 -- Alzheimer disease (AD) and diverse non-AD tau pathologies may contribute to late-life mood disorders (LLMDs), according to a study published online June 9 in Alzheimer's & Dementia.
Shin Kurose, from the National Institutes for Quantum Science and Technology in Japan, and colleagues examined the involvement of AD and non-AD tau pathologies in a study involving 52 participants with LLMDs and 47 age- and sex-matched healthy controls. Participants underwent tau and amyloid beta (Aβ) positron emission tomography (PET) imaging using 18F-florzolotau and 11C-Pittsburgh compound B. In addition, a clinicopathological correlation analysis was conducted in 208 autopsy cases, including neurodegenerative diseases.
The researchers found that compared with healthy controls, participants with LLMDs were more likely to be tau PET- and Aβ PET-positive. These results were supported by the postmortem results that showed higher likelihood of diverse tauopathies in patients with versus those without late-life mania or depression.
"Because most of the participants with LLMDs in our study had no or mild cognitive decline, these results support the evidence that neurodegenerative diseases, including Alzheimer and non-Alzheimer tau-related pathologies, can initially manifest as psychiatric symptoms," Kurose said in a statement.
Two authors hold patents on compounds related to this study.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-01 06:00
Read more

- Seniors With Certain Cardiovascular Diseases Saw Life's Essential 8 Scores Decline 2013 to 2018
- Patients With Leukemia Have Higher Infection Risk During Immunoglobulin Replacement Therapy
- Florida Officials Warn About Raw Milk After 21 People Are Sickened
- Stalking Victims At Higher Risk For Future Heart Problems
- A Happy Childhood Can Protect Against Eating Disorders
- Novartis Ianalumab Phase III Trial Meets Primary Endpoint in ITP, Demonstrating Statistically Significant Improvement in Time to Treatment Failure
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions